---
trial_id: 1062
discovery_date: 2022-07-01 09:01:12.729812
date: 2022-07-01 09:01:12.729812
title: "A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositi ..."
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04251533'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
